Add BrightSurf on Google Email

National Institutes of Health Awards Cleveland Clinic $10.7 Million to expand national consortium studying Dementia with Lewy Bodies

The National Institutes of Health has awarded a $10.7 million grant to Cleveland Clinic to expand a national research consortium focused on improving diagnosis and treatments for Dementia with Lewy Bodies. The consortium, which includes multiple clinical sites, aims to identify biomarkers for disease and develop new therapies.

C-Path awarded FDA grant to establish public-private partnership to advance treatments for rare neurodegenerative diseases

The Critical Path Institute (C-Path) has established a public-private partnership with the FDA and NIH to advance treatments for rare neurodegenerative diseases. The partnership will leverage C-Path's expertise in data management, quantitative analytics, and regulatory science to accelerate medical product development.

Researchers visualize α-synuclein pathology in living patients with a neurodegenerative disorder

Researchers have successfully visualized α-synuclein aggregates in the brains of patients with multiple system atrophy (MSA) using a new positron emission tomography (PET) imaging agent. The agent, 18F-SPAL-T-06, shows high specificity and potential for MSA diagnosis.

SourceThe National Institutes for Quantum Science and Technology·JournalMovement Disorders·TypeImaging analysis·DateAug 30, 2022

Molecular switch controls life expectancy

A new study reveals that the protein CHIP can regulate insulin receptor signals more efficiently alone than in a paired state. This finding suggests that maintaining a balance between monomeric and dimeric states of CHIP is crucial for proper cellular function.

SourceUniversity of Cologne·JournalMolecular Cell·TypeExperimental study·DateAug 25, 2022

KAIST research team proves how a neurotransmitter may be the key in controlling Alzheimer’s toxicity​

A KAIST research team has discovered a new role for somatostatin, a protein-based neurotransmitter, in reducing the toxicity caused by Alzheimers disease. When somatostatin is met with copper and Aβ proteins, it attenuates the toxicity and agglomeration of metal-Aβ complexes.

SourceThe Korea Advanced Institute of Science and Technology (KAIST)·JournalNature Chemistry·TypeExperimental study·DateJul 29, 2022

Discovery of molecular signatures of immature neurons in the human brain throughout life provide new insights into brain plasticity and other functions, according to Penn Medicine researchers

A team of researchers has used advanced techniques to identify immature hippocampal neurons in significant numbers throughout the human lifespan. The findings resolve a long-running controversy over adult neurogenesis and provide insights into brain plasticity, memory, mood, behavior, and brain disorders.

SourceUniversity of Pennsylvania School of Medicine·JournalNature·TypeRandomized controlled/clinical trial·DateJul 18, 2022

“Punch-drunk slugnuts” and the language of violence: Tracing the impact of sports slang on modern perceptions of neurodegenerative disease

A study by Stephen T. Casper examines how sports slang, such as 'punch-drunk,' influenced the conceptualization and treatment of brain injuries. The research reveals a culture that stigmatized sufferers and normalized male violence, making it difficult for medical professionals to diagnose and treat neurodegenerative disease.

SourceUniversity of Chicago Press Journals·JournalIsis·TypeContent analysis·DateJun 28, 2022

Mount Sinai researchers learn that ALS may be linked to both the immune and central nervous systems

Researchers from Mount Sinai found a significant connection between the immune system and amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease. The study analyzed mice and human samples using state-of-the-art technologies, revealing peculiar immune signatures that distinguish different forms of ALS.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature·TypeExperimental study·DateJun 22, 2022

Gold ribbon not necessary—healthy brain and body function are the rewards in this game

Researchers from the University of Tsukuba found that Synapsology, a game-like dual-task exercise, helps maintain or improve cognitive and physical abilities in older adults aged 85-97. The study, published in Alzheimer's & Dementia, suggests that this cost-effective intervention can have a societal impact.

SourceUniversity of Tsukuba·JournalAlzheimer s & Dementia Translational Research & Clinical Interventions·DateJun 15, 2022

Overlooked proteins may be key to better diagnosis of Alzheimer’s

A recent study at UC San Francisco discovered that fragmented tau protein in diseased neurons could be a new target for existing drugs, potentially improving diagnosis and treatment of Alzheimer's. The researchers found that measuring the fragments in cerebrospinal fluid may help distinguish between different forms of dementia.

SourceUniversity of California - San Francisco·JournalNeuropathology and Applied Neurobiology·DateJun 2, 2022

Researchers discover the mechanism responsible for information transfer between different regions of the brain

A new study by Bar-Ilan University researchers reveals that synchronized brain activity is crucial for information transfer between brain regions. Increasing synchronization improves transmission and processing of information, while decreasing it impairs cognitive function. This finding may contribute to the development of treatments f...

SourceBar-Ilan University·JournalCell Reports·DateMay 25, 2022

New ALS ‘drug’ is more effective than existing ones

Research on experimental drug NU-9 invents by Northwestern University scientists reveals it is more effective than existing FDA-approved drugs for ALS treatment. NU-9 also repairs the axons of diseased upper motor neurons in ALS mouse model, offering a potential new approach to treating the devastating disease.

SourceNorthwestern University·JournalScientific Reports·TypeExperimental study·DateMay 17, 2022

Circuit model may explain how deep brain stimulation treats Parkinson’s disease symptoms

A new circuit model provides an explanation for how deep brain stimulation (DBS) relieves Parkinson's disease motor symptoms by interrupting a vicious cycle between the subthalamic nucleus and the striatum. The model suggests that DBS restores a balance with other rhythm frequencies, enabling better movement control.

SourcePicower Institute at MIT·JournalProceedings of the National Academy of Sciences·TypeComputational simulation/modeling·DateMay 16, 2022

Involving patients with Parkinson’s disease in research benefits everyone

The authors of a Call to Action emphasize the value of incorporating patient perspectives in clinical Parkinson's disease studies and recommend how to include patient researchers effectively. Patient involvement can help design better studies, ensure tolerable protocols, and improve research outcomes. However, specific challenges must ...

SourceIOS Press·JournalJournal of Parkinson’s Disease·TypeCommentary/editorial·DateMay 10, 2022

Faecal transplants reverse hallmarks of ageing

Scientists have found that transplanting faecal microbiota from young mice into old mice can reverse hallmarks of ageing in the gut, eyes, and brain. The study suggests that gut microbes play a role in regulating some of the detrimental effects of ageing, offering a potential solution in the form of gut microbe replacement therapy.

SourceUniversity of East Anglia·JournalMicrobiome·TypeExperimental study·DateMay 4, 2022

Artificial intelligence aids to diagnose mild cognitive impairment that progresses to Alzheimer's

A new AI-based method distinguishes between stable and progressive cognitive impairment, enabling accurate diagnosis with an accuracy rate of 85%. This technique overcomes the complexity of subtle structural changes in mild cognitive impairment, contributing to achieving Sustainable Development Goal 3.

SourceUniversitat Oberta de Catalunya (UOC)·JournalIEEE Journal of Biomedical and Health Informatics·DateApr 27, 2022

Electronic implant reactivates spinal-cord nerves of a patient with neurodegenerative disease

A groundbreaking system implanted directly on the spinal cord has restored blood pressure regulation in a patient with multiple system atrophy-parkinsonian type (MSA-P), enabling them to walk again after being bedridden for over a year. This innovative therapy paves the way for new clinical breakthroughs in treating degenerative diseases.

SourceEcole Polytechnique Fédérale de Lausanne·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateApr 6, 2022

Alzheimer’s disease: The identification of 75 genetic risk factors brings new insights

Researchers have identified 75 regions of the genome associated with Alzheimer's disease, including 42 novel regions. The study confirms the importance of pathological processes such as amyloid peptide production and tau protein function in the disease. A genetic risk score has also been devised to better evaluate patient risk.

SourceINSERM (Institut national de la santé et de la recherche médicale)·JournalNature Genetics·TypeObservational study·DateApr 4, 2022

Insilico Medicine identifies potential dual-purpose therapeutic targets implicated in aging and age-associated diseases using Artificial Intelligence and hallmarks of aging framework

Researchers at Insilico Medicine have used AI to identify potential targets that are implicated in multiple age-related diseases and also play a role in the basic biology of aging. The study resulted in the identification of 69 high-confidence targets with potential high druggability.

SourceInSilico Medicine·JournalAging-US·DateMar 29, 2022